
Sign up to save your podcasts
Or
Anaphylaxis specialist Jay Lieberman, MD, FAAAAI, tells us everything we need to know about the first FDA approved epinephrine nasal spray to treat type 1 allergic reactions and anaphylaxis. (Participants in this podcast have disclosed a past financial relationship with the drug manufacturer.)
4.7
4747 ratings
Anaphylaxis specialist Jay Lieberman, MD, FAAAAI, tells us everything we need to know about the first FDA approved epinephrine nasal spray to treat type 1 allergic reactions and anaphylaxis. (Participants in this podcast have disclosed a past financial relationship with the drug manufacturer.)
707 Listeners
3,336 Listeners
111,917 Listeners
56,277 Listeners
1,095 Listeners
194 Listeners
50 Listeners
219 Listeners
317 Listeners
15,335 Listeners
2 Listeners
377 Listeners
0 Listeners
51 Listeners
1,094 Listeners